Related Experiment Video

Updated: Jun 19, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

[Value of the laboratory markers of endothelial damage in unstable angina pectoris]

V Iu Smirnova

    Klinicheskaia Laboratornaia Diagnostika
    |October 15, 2009
    PubMed

    Insights

    Patients with severe ischemic heart disease show elevated endothelin-1 levels. C-reactive protein remained high, while pregnancy-associated plasma protein and homocysteine levels decreased significantly.

    Area of Science:

    • Cardiovascular Medicine
    • Biomarker Research
    • Clinical Chemistry

    Context:

    • Ischemic heart disease (IHD) poses a significant global health burden.
    • Identifying reliable biomarkers for IHD severity and progression is crucial for patient management.
    • Previous research has explored various biochemical markers in IHD, but comprehensive analysis is ongoing.

    Purpose:

    • To investigate the dynamic changes in specific biomarkers in patients with severe ischemic heart disease.
    • To correlate endothelin-1, C-reactive protein, pregnancy-associated plasma protein-A, and homocysteine levels with clinical presentation and disease progression.
    • To assess the potential of these markers in monitoring IHD severity.

    Summary:

    • Patients with severe ischemic heart disease exhibited significantly elevated concentrations of endothelin-1 within 24 hours and at 4 months post-observation (p < 0.05).
    • Baseline C-reactive protein levels were consistently high throughout the study period (p < 0.05).
    • A significant reduction in plasma levels of pregnancy-associated plasma protein-A (p < 0.05) and homocysteine (p < 0.01) was observed in these patients.

    Impact:

    • These findings highlight endothelin-1 as a potential indicator of IHD severity and progression.
    • The observed reduction in pregnancy-associated plasma protein-A and homocysteine warrants further investigation into their roles in IHD.
    • Understanding these biomarker dynamics can aid in developing improved diagnostic and prognostic tools for ischemic heart disease.

    Related Concept Videos

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers

    Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
    The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
    Troponins
    Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Angina III: Clinical Manifestations and Assessment01:29

    Angina III: Clinical Manifestations and Assessment

    Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

    The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...